Sue-Anne McLachlan

An exploration of the perceptions, experience and practice of cancer clinicians in caring for patients with cancer who are also parents of dependent-age children.

Sarah Heynemann, Jennifer Philip, Sue-Anne McLachlan

Journal article  |  2021  |  Support Care Cancer

BACKGROUND: Being a parent alongside a cancer diagnosis presents unique challenges. It is unclear to what degree parenting conside..

Financial toxicity in patients with cancer attending a public Australian tertiary hospital: A pilot study.

Luke McLean, Wei Hong, Sue-Anne McLachlan

Journal article  |  2021  |  Asia Pac J Clin Oncol

AIM: As therapeutic options for cancer evolve and become more complex, the concept of financial toxicity has emerged. The comprehe..

Care plus study: a multi-site implementation of early palliative care in routine practice to improve health outcomes and reduce hospital admissions for people with advanced cancer: a study protocol

Jennifer Philip, Roslyn Le Gautier, Anna Collins, Anna K Nowak, Brian Le, Gregory B Crawford, Nicole Rankin, Meinir Krishnasamy, Geoff Mitchell, Sue-Anne McLachlan, Maarten IJzerman, Robyn Hudson, Danny Rischin, Tanara Vieira Sousa, Vijaya Sundararajan

Journal article  |  2021  |  BMC HEALTH SERVICES RESEARCH

BACKGROUND: Current international consensus is that 'early' referral to palliative care services improves cancer patient and famil..

Chemotherapy at the end of life in colorectal and pancreatic cancer: Real-world data and trends over time.

Catherine Dunn, Belinda Lee, Jeremy David Shapiro, Rachel Wong, Grace Gard, Michael Michael, Wei Hong, Matthew E Burge, Vanessa Wong, Ben Thomson, Sumitra Ananda, Sue-Anne McLachlan, Brett Knowles, Mehdrad Nikfarjam, Jeanne Tie, Ross Jennens, Joseph James McKendrick, Margaret Lee, Suzanne Kosmider, Peter Gibbs

Conference Proceedings  |  2021  |  Journal of Clinical Oncology

e18723 Background: Chemotherapy at the end of life (CEOL) is widely accepted as an indicator of aggressive care. However, the evi..

Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR study

Michael Michael, Winston Liauw, Sue-Anne McLachlan, Emma Link, Annetta Matera, Michael Thompson, Michael Jefford, Rod J Hicks, Carleen Cullinane, Athena Hatzimihalis, Ian G Campbell, Simone Rowley, Phillip J Beale, Christos S Karapetis, Timothy Price, Mathew E Burge

Journal article  |  2021  |  CANCER CHEMOTHERAPY AND PHARMACOLOGY

PURPOSE: Irinotecan (IR) displays significant PK/PD variability. This study evaluated functional hepatic imaging (HNI) and extensi..

Survival from breast cancer in women with a BRCA2 mutation by treatment

D Gareth Evans, Kelly-Anne Phillips, Roger L Milne, Robert Fruscio, Cezary Cybulski, Jacek Gronwald, Jan Lubinski, Tomasz Huzarski, Zerin Hyder, Claire Forde, Kelly Metcalfe, Leigha Senter, Jeffrey Weitzel, Nadine Tung, Dana Zakalik, Maria Ekholm, Ping Sun, Steven A Narod

Journal article  |  2021  |  BRITISH JOURNAL OF CANCER

BACKGROUND: The impact of various breast-cancer treatments on patients with a BRCA2 mutation has not been studied. We sought to es..

Pilot Study of Patients' Preferences for Immediate Resection Versus a Watch and Wait Approach After Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer.

Ashray Gunjur, Grace Chazan, Genni Newnham, Sue-Anne McLachlan

Journal article  |  2021  |  JCO Oncol Pract

PURPOSE: In patients with rectal cancer who achieve a clinical complete response to neoadjuvant chemoradiation, it may be reasonab..

Motivators of Inappropriate Ovarian Cancer Screening: A Survey of Women and Their Clinicians

Courtney Macdonald, Danielle Mazza, Martha Hickey, Morgan Hunter, Louise A Keogh, Sandra C Jones, Christobel Saunders, Stephanie Nesci, Roger L Milne, Sue-Anne Mclachlan, John L Hopper, Michael L Friedlander, Jon Emery, Kelly-Anne Phillips

Journal article  |  2021  |  JNCI CANCER SPECTRUM

Background: This study examined why women and doctors screen for ovarian cancer (OC) contrary to guidelines. Methods: Surveys, bas..

CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

Nichola Johnson, Sarah Maguire, Anna Morra, Pooja Middha Kapoor, Katarzyna Tomczyk, Michael E Jones, Minouk J Schoemaker, Clare Gilham, Manjeet K Bolla, Qin Wang, Joe Dennis, Thomas U Ahearn, Irene L Andrulis, Hoda Anton-Culver, Natalia N Antonenkova, Volker Arndt, Kristan J Aronson, Annelie Augustinsson, Caroline Baynes, Laura E Beane Freeman, et al.

Journal article  |  2021  |  BRITISH JOURNAL OF CANCER

BACKGROUND: Epidemiological studies provide strong evidence for a role of endogenous sex hormones in the aetiology of breast cance..

Breast Cancer Chemoprevention: Use and Views of Australian Women and Their Clinicians

Courtney Macdonald, Christobel M Saunders, Louise A Keogh, Morgan Hunter, Danielle Mazza, Sue-Anne Mclachlan, Sandra C Jones, Stephanie Nesci, Michael L Friedlander, John L Hopper, Jon D Emery, Martha Hickey, Roger L Milne, Kelly-Anne Phillips

Journal article  |  2021  |  CANCER PREVENTION RESEARCH

Guidelines endorse the use of chemoprevention for breast cancer risk reduction. This study examined the barriers and facilitators ..